期刊文献+

苯丁酸钠对喉癌Hep-2细胞株诱导化疗的影响 被引量:1

The effect of sodium phenylbutyrate to agents used in induction chemotherapy on laryngeal carcinoma cells Hep-2 in vitro
原文传递
导出
摘要 目的:研究苯丁酸钠(PB)与诱导化疗药物对体外喉癌Hep2细胞株的联合作用,探讨PB对喉癌诱导化疗的影响。方法:采用四甲基偶氮唑蓝法(MTT)检测PB分别与5氟脲嘧啶(5FU)和顺铂(CDDP)联合作用时对喉癌细胞的生长抑制作用。结果:5FU和CDDP分别与PB联合应用时,两药各个剂量组与对照组比较及各个剂量组之间比较,差异均有统计学意义(均P<0.05);当5FU和CDDP的浓度一定时,PB的各个剂量组之间比较差异均有统计学意义(均P<0.05)。结论:PB能增强诱导化疗药物对体外喉癌细胞的细胞毒作用,为临床增强喉癌诱导化疗的疗效,减少并发症和毒性反应的发生提供了新的思路。 Objective:To study the effect of sodium phenylbutyrate when it combined with agents used in induction chemotherapy on laryngeal carcinoma cells Hep-2 in vitro.Method:MTT were used to examine the growth inhibition of Hep-2 cells treated by the combination of PB with 5-FU or CDDP in vitro.Result:When 5-FU or CDDP combined with PB respectively,there was significantly difference between every two dose groups of the two agents or every dose group and control group(P<0.05).When the dosage of 5-FU or CDDP was definition,there was significantly difference between every two dose groups of PB(P<0.05).Conclusion:PB could enhance the cytotoxic effects of agents used in induction chemotherapy on laryngeal carcinoma cells Hep-2 in vitro, which showed the possibility in reinforcement the treatment effect and reduction the occurence of the complication and toxic reaction of induction chemotherapy on laryngeal carcinoma.
出处 《临床耳鼻咽喉科杂志》 CSCD 北大核心 2005年第15期680-682,共3页 Journal of Clinical Otorhinolaryngology
关键词 苯丁酸钠 喉肿瘤 诱导化疗 5-氟脲嘧啶 顺铂 Sodium phenylbutyrate Laryngeal neoplasms Induction chemotherapy 5-Flucytosine Cisplatin
  • 相关文献

参考文献8

  • 1Gore S D,Weng L J,Figg W D,et al. Impact of prolonged infusions of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia. Clin Cancer Res,2002,8:963-970.
  • 2Goh M, Chen F, Paulsen M T, et al. Phenylbutyrate attenuates the expression of Bcl-X(L), DNA-PK, caveolin-1, and VEGF in prostate cancer cells. Neoplasia, 2001, 3: 331-338.
  • 3Ammerpohl O, Thormeyer D, Khan Z, et al. HDACi phenylbutyrate increases bystander killing of HSV-tk transfected glioma cells. Biochem Biophys Res Commun, 2004, 324: 8-14.
  • 4Feinman R, Clarke K O, Harrison L E. Phenylbutyrate-induced apoptosis is associated with inactivation of NF-kappaB in HT-29 colon cancer cells. Cancer Chemother Pharmacol,2002, 49: 27-34.
  • 5Wang Q M,Feinman R,Kashanchi F,et al.Changes in E2F binding after phenylbutyrate-induced differentiation of Caco-2 colon cancer cells.Clin Cancer Res,2000,6:2951-2958.
  • 6Chung Y L, Lee Y H, Yen S H,et al. A novel approach for nasopharyngeal carcinoma treatment uses phenylbutyrate as a protein kinase C modulator: implications for radiosensitization and EBV-targeted therapy. Clin Cancer Res, 2000, 6: 1452-1458.
  • 7Ferrandina G, Filippini P, Ferlini C, et al. Growth inhibitory effects and radiosensitization induced by fatty aromatic acids on human cervical cancer cells. Oncol Res, 2000,12(9-10):429-440.
  • 8许光普,曾宗渊,陈福进,魏茂文,夏良平.新辅助化疗治疗喉癌喉咽癌的近期疗效评价[J].临床肿瘤学杂志,2002,7(6):413-415. 被引量:8

二级参考文献10

  • 1Keum KC,Kim GE,Suh CO,et al.Role of definitive radiation therapy for larynx preservation in patients with advanced laryngeal cancer[J].J Otolaryngol,1999,28(5):245-51.
  • 2EL-sayed SS,Nelson N.Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region:Aa meta-analysis of prospective and randomized trials[J].J Clin Oncol,1996,14(3):838-847.
  • 3Forastiere AA.Head and Neck cancer.Overview of recent developments and future directions[J].Seminar Oncol,2000,27(4 suppl 8):1-4.
  • 4Posner MR,Colevas D,Tisher RB.The role of induction chemotherapy in the curative treatment of squamous cell cancer of the Head and Neck[J].Seminar Oncol,2000,27(4 suppl 8):13-24.
  • 5Kim S,Wu HG,Heo,DS,et al.Advanced hypopharyngeal carcinoma treatment results according to treatment modalities[J].Head Neck,2001,23(9):713-7
  • 6Kim KH,Sung MW,Rhee CS,et al.Neoadjuvant chemotherapy and radiotherapy for the treatment of advanced hypopharyngeal carcinoma[J].Am J Otolaryngol,1998,19(1):40-4.
  • 7DelGaudio JM,Fleming DJ,Esclamado RM,et al.Hemilaryngectomy for glottic carcinoma after radiation therapy failure[J].Arch Otolaryngol Head Neck Surg,1994,120(9):959-963.
  • 8Spaulding MB,Fischer SG,Wolf GT.Tumor response,toxicity,and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma.The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group[J].J Clin Oncol,1994,12(8):1592-1599.
  • 9Clayman.Laryngeal preservation For advanced laryngeal and hypopharyngael cancers[J].Arch otolaryngeal Head Neck Surg, 1995,121(2):219-223.
  • 10房居高,梁恩虎,栾信庸,王天铎.保留喉功能的梨状窝癌的综合治疗[J].临床耳鼻咽喉科杂志,2000,14(3):104-105. 被引量:6

共引文献7

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部